June 21, 2024 07:00 AM EDTUpdated February 6, 09:00 AM
Peer Review

Mon­cef Slaoui joins board at mR­NA biotech; Gami­da Cell re­tools with ex-Am­ryt CEO at the helm

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Mon­cef Slaoui has reemerged this week with an­oth­er board ap­point­ment, mak­ing his way to mR­NA drug de­vel­op­er Arc­turus Ther­a­peu­tics. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times